{"created":"2023-07-25T09:03:52.941796+00:00","id":1646,"links":{},"metadata":{"_buckets":{"deposit":"d8cf6cbb-a18b-4ffb-a9f8-c96a1123a26e"},"_deposit":{"created_by":3,"id":"1646","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"1646"},"status":"published"},"_oai":{"id":"oai:toyama.repo.nii.ac.jp:00001646","sets":["208:211:251:310"]},"author_link":["4263"],"item_3_alternative_title_19":{"attribute_name":"その他（別言語等）のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"An Analysis on Distribution Systems in Pharmaceutical Industries in Japan (3) : Effects and Regulations in Current Distribution Systems of Drugs"}]},"item_3_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1989-02","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"2","bibliographicPageEnd":"432","bibliographicPageStart":"389","bibliographicVolumeNumber":"34","bibliographic_titles":[{"bibliographic_title":"富山大学紀要．富大経済論集"}]}]},"item_3_description_15":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"application/pdf","subitem_description_type":"Other"}]},"item_3_description_40":{"attribute_name":"資源タイプ(DSpace)","attribute_value_mlt":[{"subitem_description":"Article","subitem_description_type":"Other"}]},"item_3_description_6":{"attribute_name":"引用","attribute_value_mlt":[{"subitem_description":"富山大学紀要．富大経済論集，第34巻第2号，1989.02，pp. 389-432","subitem_description_type":"Other"}]},"item_3_full_name_3":{"attribute_name":"著者別名","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"4263","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"9000002305655","nameIdentifierScheme":"CiNii ID","nameIdentifierURI":"http://ci.nii.ac.jp/nrid/9000002305655"},{"nameIdentifier":"10019086","nameIdentifierScheme":"e-Rad","nameIdentifierURI":"https://nrid.nii.ac.jp/nrid/1000010019086"}],"names":[{"name":"Ohara, Hisaharu"}]}]},"item_3_identifier_registration":{"attribute_name":"ID登録","attribute_value_mlt":[{"subitem_identifier_reg_text":"10.15099/00001640","subitem_identifier_reg_type":"JaLC"}]},"item_3_publisher_33":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"富山大学経済学部"}]},"item_3_source_id_10":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00408391","subitem_source_identifier_type":"NCID"}]},"item_3_source_id_8":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"02863642","subitem_source_identifier_type":"ISSN"}]},"item_3_version_type_16":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"小原, 久治"}],"nameIdentifiers":[{},{},{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2016-02-15"}],"displaytype":"detail","filename":"34-2_01-10_Page389to432_Ohara.pdf","filesize":[{"value":"2.0 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"34-2_01-10_Page389to432_Ohara.pdf","url":"https://toyama.repo.nii.ac.jp/record/1646/files/34-2_01-10_Page389to432_Ohara.pdf"},"version_id":"663f5fa3-91ee-44c5-976a-4ee73752900d"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"製薬企業","subitem_subject_scheme":"Other"},{"subitem_subject":"流通システム","subitem_subject_scheme":"Other"},{"subitem_subject":"医薬品産業","subitem_subject_scheme":"Other"},{"subitem_subject":"流通系列化","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"製薬企業における流通システムの分析 (3) : 現行の医薬品流通システムの効果と規制","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"製薬企業における流通システムの分析 (3) : 現行の医薬品流通システムの効果と規制"}]},"item_type_id":"3","owner":"3","path":["310"],"pubdate":{"attribute_name":"公開日","attribute_value":"2015-07-22"},"publish_date":"2015-07-22","publish_status":"0","recid":"1646","relation_version_is_last":true,"title":["製薬企業における流通システムの分析 (3) : 現行の医薬品流通システムの効果と規制"],"weko_creator_id":"3","weko_shared_id":3},"updated":"2023-07-25T12:35:17.328135+00:00"}